The first stop for professional medicines advice

Medication Safety, Medicine

17 results

Applied filters

Using potassium permanganate for skin conditions or wound care

4 April 2025Potassium permanganate is a chemical product. We review the evidence for using it in wound care and highlight the risk of severe harm associated with wrong use.

Developing opioid safety across a system

26 March 2025Strategies and signposting to support safer use of opioids for chronic, non-cancer pain.

Supporting safe use of adrenal crisis emergency management kits

18 November 2024Treatment of adrenal crisis is time critical and relies on timely use of injectable hydrocortisone to prevent harm.

Managing the risk of confusion between injectable penicillin salts

4 October 2024Minimising the risk of confusion between injectable benzylpenicillin salt formulations may prevent harms.

Managing risks associated with oxytocin infusions during labour

24 September 2024Safety strategies can minimise the risk of harms related to oxytocin infusion overdose and delayed therapy.

Using amphotericin B injections

13 September 20243 formulations exist: 1 conventional; 2 liposomal. Conventional and liposomal formulations are not interchangeable; liposomal formulations are interchangeable.

Assessing injectables for enteral administration

13 August 2024Clinical decisions on the use of injectable formulations for enteral administration should be guided by safety and practicality.

Managing the risks associated with patients prescribed clozapine

28 June 2024Healthcare professionals in non-specialist services managing patients prescribed clozapine should implement safe practice principles to prevent potential harms.

Clinical considerations for patients prescribed clozapine

28 June 2024Healthcare professionals in all settings who interact with patients prescribed clozapine should be aware of clinical considerations related to its use.

Ensuring time critical use of rasburicase

6 March 2024Timely use of rasburicase for treatment of Tumour Lysis Syndrome is essential. Mitigation strategies can minimise harm associated with delayed therapy.